focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEn+ Group S Regulatory News (ENPL)

  • This share is currently suspended. It was suspended at a price of 9.30

Share Price Information for En+ Group S (ENPL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.30
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.30
ENPL Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CLARIFICATION ON THE FINANCIAL STATEMENT

22 Dec 2017 13:25

RNS Number : 2383A
EN+ Group PLC
22 December 2017
 

**NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA, OR TO ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL**

 

CLARIFICATION ON THE FINANCIAL STATEMENT

22 December 2017 - Further to the publication by En+ Group PLC (the "Company") of the Consolidated Interim Condensed Financial Information for the three and nine months ended 30 September 2017 for the Company and its subsidiaries (the "Group") on 4 December 2017, the Company wishes to clarify that, consistent with the regulatory announcements on 3 November 2017, 10 November 2017, 17 November 2017 and 24 November 2017 released by VTB Capital plc in accordance with the Market Abuse Regulation (EU) No. 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 in relation to stabilisation activity, the Over-Allotment Option in relation to the Company's initial public offering of GDRs was not exercised during the Stabilisation Period.

***

For further information, please visit http://enplus.ru or contact:

 

For media:

 

For investors:

Andrey Petrushinin

Ignatiy Pavlov

Tel: +7 495 642 79 37

Email: press-center@enplus.ru

Daria Fadeeva

 

Tel: +7 (495) 642 7937

Email: ir@enplus.ru

 

***

Copies of this announcement are not being made and may not be distributed or sent, directly or indirectly, into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Canada, Japan, Australia, or to any other jurisdiction where to do so would be unlawful.

This announcement is not and does not form part of any offer or solicitation to purchase or subscribe for securities in the United States. The securities referred to herein may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended. En+ Group does not intend to register any portion of the offering of any securities referred to herein in the United States or to conduct a public offering of the securities in the United States.

This communication does not constitute an offer of any securities to the public in the United Kingdom. This communication is being distributed to and is directed only at (i) persons who are outside the United Kingdom, (ii) persons who are investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended from time to time (the "Order"), (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order and (iv) persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities of the Company or any member of its group may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "Relevant Persons"). Any investment activity to which this communication relates will only be available to and will only be engaged in with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this document or any of its contents.

This communication is distributed in any member state of the European Economic Area ("EEA") which applies Directive 2003/71/EC (this Directive together with any amendments thereto including Directive 2010/73/EU to the extent implemented in such member state of the EEA and any implementing measures in any member state, the "Prospectus Directive") only to those persons who are qualified investors for the purposes of the Prospectus Directive ("Qualified Investors") in such member state, and such other persons as this document may be addressed on legal grounds, and no person that is not a relevant person or Qualified Investor may act or rely on this document or any of its contents.

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Group's business, results of operations, financial position, liquidity, prospects, growth or strategies. Forward-looking statements speak only as of the date they are made.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEMFFEFWSEEE
Date   Source Headline
26th Apr 20244:00 pmRNSEN+ GROUP's Consolidated (Annual) Report 2023
21st Mar 20247:00 amRNSFinal Results
20th Dec 20234:30 pmRNSDirectorate Change
17th Aug 20238:00 amRNSEN+ GROUP 1H 2023 FINANCIAL RESULTS
11th Aug 202310:00 amRNSACRA ASSIGNS EN+ GROUP A-(RU) CREDIT RATING
29th Jun 20234:00 pmRNSResults of the meeting of the Board of EN+ GROUP
29th Jun 20233:00 pmRNSEN+ GROUP 2023 AGM Results
24th May 20235:00 pmRNSEN+ GROUP IPJSC announces its 2023 AGM
28th Apr 20233:00 pmRNSEN+ GROUP's Consolidated (Annual) Report 2022
4th Apr 20231:00 pmRNSEN+ GROUP announces Director's appointment
23rd Mar 20237:00 amRNSAnnual Financial Report
22nd Aug 20224:00 pmRNSACRA ASSIGNS EN+ A-(RU) CREDIT RATING
18th Aug 20224:00 pmRNSEN+ intends to start automatic conversion of GDRs
18th Aug 20228:00 amRNSEN+ GROUP 1H 2022 FINANCIAL RESULTS
18th Aug 20228:00 amRNSResults of the Board meeting of EN+ GROUP IPJSC
28th Jul 20224:00 pmRNSInformation for holders of the Company's GDRs
6th Jul 20224:00 pmRNSEN+ announces director's resignation
23rd Jun 20226:00 pmRNSResults of the Board Meeting of EN+ GROUP
23rd Jun 20225:00 pmRNSEN+ GROUP 2022 AGM Results
31st May 20224:30 pmRNSEN+ PUBLISHES 2021 SUSTAINABILITY REPORT
31st May 20224:30 pmRNSEN+ announces additional information on AGM 2022
25th May 20226:00 pmRNSDirectorate Change
19th May 20223:30 pmRNSPermit to continue the circulation of GDRs abroad
18th May 20224:00 pmRNSEN+ GROUP announces Directors’ appointments
18th May 20224:00 pmRNSEN+ GROUP announces its 2022 AGM
5th May 20227:00 amRNSEn+ application for circulation of GDRs abroad
29th Apr 20222:00 pmRNSEN+ GROUP’s Annual Report 2021
19th Apr 20228:00 amRNSEN+ announcements re its GDR Deposit Agreements
11th Apr 20227:00 amRNSEN+ statement re European Council announcement
7th Apr 20221:45 pmRNSCiti Opens Books for EN+ DR Program Cancellation
1st Apr 20227:00 amRNSEN+ ANNOUNCES DIRECTOR’S RESIGNATION
31st Mar 20227:00 amRNSEN+ GROUP FY 2021 FINANCIAL RESULTS
25th Mar 20222:00 pmRNSEN+ ANNOUNCES BOARD CHANGES
21st Mar 20224:00 pmRNSRUSAL ANNOUNCEMENT RE AUSTRALIAN BAN ON EXPORT
10th Mar 20224:30 pmRNSEN+ statement re UK government announcement
7th Mar 20227:00 amRNSEN+ statement re press comment
7th Mar 20227:00 amRNSEN+ announces directors’ resignations
1st Mar 20225:00 pmRNSHALT IN PRODUCTION AT NIKOLAEV ALUMINA REFINERY
9th Feb 20227:00 amRNSEN+ GROUP ANNOUNCES 4Q AND FY 2021 TRADING UPDATE
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20214:00 pmRNSEN+ announces Director's appointment
9th Dec 20212:00 pmRNSEN+ announces Director's resignation
18th Nov 20214:41 pmRNSSecond Price Monitoring Extn
18th Nov 20214:35 pmRNSPrice Monitoring Extension
1st Nov 20219:00 amRNSDEMERGER OF RUSAL HIGH CARBON BUSINESSES
27th Oct 20217:00 amRNSEN+ GROUP ANNOUNCES 9M AND 3Q 2021 TRADING UPDATE
21st Sep 20218:10 amRNSBUDWEISER, EN+, CANPACK AND ELVAL PILOT BEER CAN
20th Sep 20217:00 amRNSEn+ Group publishes Pathway to Net Zero
15th Sep 20213:14 pmRNSEN+ NET ZERO INVESTOR WEBINAR ON SEPTEMBER 22

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.